LobbyingAdvanced Oxygen Therapy lobbying by quarter
Advanced Oxygen Therapy's latest lobbying report covers Q2 2026, at $30K. The four quarters Q3 2025–Q2 2026 total $120K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Advanced Oxygen Therapy
- Latest quarter
- $30K
- Q2 2026 · 1 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $50K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $30K | 1 |
Policy issues the reports name
- Medicare and Medicaid14 reports
- Health issues7 reports
- Veterans7 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES10 reports
- SENATE7 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Alston & Bird | $200K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EARL POMEROY | Congressman, U.S. House of Representatives | Q3 2023 |
| MARK RAYDER | LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo. | Q3 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Alston & Bird | $30K |
| 04/20for Q1 | Alston & Bird | Under $5,000 |
| 01/20for Q4 2025 | Alston & Bird | $40K |
| 25/10/20for Q3 2025 | Alston & Bird | $50K |
| 25/07/21for Q2 2025 | Alston & Bird | Under $5,000 |
| 25/04/21for Q1 2025 | Alston & Bird | Under $5,000 |
| 25/01/21for Q4 2024 | Alston & Bird | $10K |
| 24/10/21for Q3 2024 | Alston & Bird | Under $5,000 |
| 24/07/22for Q2 2024 | Alston & Bird | Under $5,000 |
| 24/04/22for Q1 2024 | Alston & Bird | Under $5,000 |
| 24/01/22for Q4 2023 | Alston & Bird | Under $5,000 |
| 23/10/20for Q3 2023 | Alston & Bird | $50K |
| 23/07/19for Q2 2023 | Alston & Bird | $10K |
| 23/04/20for Q1 2023 | Alston & Bird | $10K |
| 23/01/20for Q4 2022 | Alston & Bird | Under $5,000 |